Sulzer Medica float will go ahead says CEO (Chief Executive Officer):
This article was originally published in Clinica
Executive Summary
The CEO of Sulzer, the parent company that owns 74% of Sulzer Medica, said last week that the ongoing recall and programme of revision surgery presently affecting Sulzer Medica will not delay the scheduled flotation on July 10. Fred Kindle also told Finanz und Wirtschaft that the lawyers had ruled out the parent company assisting Sulzer Medica if the damages reach the estimated $1 billion.